PROTOCOL SPECIFIC RESEARCH SUPPORT

9.3特定于协议的研究支持(本地命名为特定于协议的数据管理) 根据国家癌症研究所关于癌症中心的政策和指南 Support Grant，这个由研究护士和数据管理人员组成的核心团队提供集中管理和 协调、促进和报告癌症临床试验的监督职能 中心。最重要的是确定和支持由以下项目产生的第一和第二阶段试验 由癌症中心附属内科医生-科学家产生的工作。优先提供支持以确保启动 以及完成源自该中心的创新、可行性或原则验证的临床试验 项目和中心最优先考虑的项目。这些包括任何类型的临床转化性研究 最终对候选试剂或设备进行初始早期测试，用于诊断、预防、 癌症的检测或治疗。支持这类研究工作的最终目标是促进 将可行性/第一阶段研究转化为未来的赠款申请或第二阶段和第三阶段研究 由NCI或行业支持。该小组的监督由临床副主任提供 研究。

9.3 Protocol-Specific Research Support (locally named Protocol-Specific Data Management) In accordance with the National Cancer Institute Policies and Guidelines Relating to the Cancer Center Support Grant, this core group of research nurses and data managers provides central management and oversight functions for coordinating, facilitating and reporting on the cancer clinical trials of the Cancer Center. Of primary importance is the identification and support of phase I and II trials emanating from the work generated by Cancer Center affiliated physician-scientists. Support is prioritized to ensure the initiation and completion of innovative, feasibility, or proof-of-principle clinical trials originating from the Center's Programs and of highest priority to the Center. These include any kind of clinical translational research culminating in the initial early-phase testing of a candidate agent or device for the diagnosis, prevention, detection, or treatment of cancer. The ultimate goal of supporting such research efforts is to foster the translation of feasibility/phase I studies into future grant applications or into phase II and phase III studies supported by NCI or industry. Oversight of this group is provided by the Associate Director of Clinical Research.